Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has...